Online citations, reference lists, and bibliographies.
← Back to Search

Controlled Delivery Systems: From Pharmaceuticals To Cells And Genes

E. R. Balmayor, H. Azevedo, R. Reis
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACTDuring the last few decades, a fair amount of scientific investigation has focused on developing novel and efficient drug delivery systems. According to different clinical needs, specific biopharmaceutical carriers have been proposed. Micro- and nanoparticulated systems, membranes and films, gels and even microelectronic chips have been successfully applied in order to deliver biopharmaceuticals via different anatomical routes. The ultimate goal is to deliver the potential drugs to target tissues, where regeneration or therapies (chemotherapy, antibiotics, and analgesics) are needed. Thereby, the bioactive molecule should be protected against environmental degradation. Delivery should be achieved in a dose- and time-correct manner. Drug delivery systems (DDS) have been conceived to provide improvements in drug administration such as ability to enhance the stability, absorption and therapeutic concentration of the molecules in combination with a long-term and controlled release of the drug. Moreover, the adverse effects related with some drugs can be reduced, and patient compliance could be improved. Recent advances in biotechnology, pharmaceutical sciences, molecular biology, polymer chemistry and nanotechnology are now opening up exciting possibilities in the field of DDS. However, it is also recognized that there are several key obstacles to overcome in bringing such approaches into routine clinical use. This review describes the present state-of-the-art DDS, with examples of current clinical applications, and the promises and challenges for the future in this innovative field.
This paper references
10.1016/S0168-3659(03)00258-X
In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
T. Holland (2003)
10.1016/J.BIOMATERIALS.2005.08.017
Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture.
H. Hosseinkhani (2006)
The future of multihospital systems.
L. R. Kaiser (1992)
10.1023/B:PHAM.0000029282.44140.2e
Transdermal Delivery of Insulin Using Microneedles in Vivo
Wijaya Martanto (2004)
10.1016/J.TIPS.2004.05.006
Techniques: new approaches to the delivery of biopharmaceuticals.
G. Orive (2004)
10.1016/J.TIPS.2007.10.010
Delivering growth factors for therapeutics.
E. Anitua (2008)
10.1185/030079906X167381
Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes*
R. Hayes (2007)
10.1159/000107575
Percutaneous Penetration Enhancers: An Overview
H-Y Thong (2007)
10.1016/J.TRANSPROCEED.2006.03.014
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus.
R. Calafiore (2006)
In vitro and in vivo studies on vitamin E TPGSemulsified poly(D, L-lactic-co-glycolic acid) nanoparticles for paclitaxel
KY Win (2006)
10.1016/J.TIBTECH.2003.11.004
History, challenges and perspectives of cell microencapsulation.
G. Orive (2004)
10.1016/J.NBD.2006.04.014
Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys
D. Emerich (2006)
10.1517/17425247.5.9.1047
Delivery of insulin to the buccal mucosa utilizing the RapidMist system.
G. Bernstein (2008)
10.1001/ARCHPSYC.60.2.204
Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.
J. Swanson (2003)
10.1016/S0167-7799(02)02037-1
Encapsulated cell technology: from research to market.
G. Orive (2002)
10.1146/ANNUREV.BIOENG.2.1.289
Microfabricated microneedles for gene and drug delivery.
D. Mcallister (2000)
10.1038/nrd1721
The rise and rise of drug delivery
Howard Rosen (2005)
10.1016/J.BIOMATERIALS.2003.12.032
Temperature and pH-responsive polymeric composite membranes for controlled delivery of proteins and peptides.
K. Zhang (2004)
10.1557/MRS2006.209
Use of Nanotechnologies for Drug Delivery
P. Shah (2006)
10.1177/0091270004269840
Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women
S. Davison (2005)
10.2337/DIACARE.29.01.06.DC05-1270
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases.
R. Calafiore (2006)
10.1016/j.jconrel.2008.08.005
Silk fibroin spheres as a platform for controlled drug delivery.
E. Wenk (2008)
10.1016/j.cytogfr.2009.10.001
Design of second generation therapeutic recombinant bone morphogenetic proteins.
M. Alaoui-Ismaili (2009)
10.1016/J.EJPB.2006.12.017
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
E. C. Gryparis (2007)
10.1097/01.tp.0000208610.75997.20
Six-Month Survival of Microencapsulated Pig Islets and Alginate Biocompatibility in Primates: Proof of Concept
D. Dufrane (2006)
10.3109/03639049809108573
Coatings for controlled-release drug delivery systems.
C. Rhodes (1998)
10.1201/9780203910337-51
Macroflux Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines
Michel J. N. Cormier (2002)
10.1517/17425247.5.9.1047
Delivery of insulin to the buccal mucosa utilizing the RapidMist™ system
G. Bernstein (2008)
10.1002/BIP.20509
Alginate–chitosan complex coacervation for cell encapsulation: Effect on mechanical properties and on long‐term viability
L. Baruch (2006)
10.1016/S0022-5347(05)68810-6
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.
R. Anderson (1999)
10.1038/nrd1659
Therapeutic applications of polymeric artificial cells
T. Chang (2005)
10.1201/9780203910337
Modified-Release Drug Delivery Technology
M. Rathbone (2002)
their development and testing
Wound Biotechnology (2011)
Collagen-based injectable drug delivery system and its use
JS Rosenblatt (1998)
10.1517/14712598.2.1.67
Targeting approaches to oral drug delivery
I. Lambkin (2002)
10.1213/00000539-200102000-00041
Lack of Pain Associated with Microfabricated Microneedles
S. Kaushik (2001)
10.1016/S0165-6147(98)01196-1
Strategies and technologies for drug delivery systems
K. Jain (1998)
10.1177/154405910608500710
Transplanted Endothelial Cells Enhance Orthotopic Bone Regeneration
D. Kaigler (2006)
10.1021/JS950534B
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
T. Loftsson (1996)
10.1517/17425240802567846
Polymeric carriers: role of geometry in drug delivery.
Eric A Simone (2008)
10.1016/S0165-6147(03)00073-7
Cell microencapsulation technology for biomedical purposes: novel insights and challenges.
G. Orive (2003)
10.1016/j.addr.2008.08.005
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
10.1016/S1471-4914(01)02088-3
Gene therapy strategies for urological dysfunction.
M. Chancellor (2001)
10.2174/187152206776359948
Advances and Barriers in Mammalian Cell Encapsulation for Treatment of Diabetes
P. Vos (2006)
Multilayered hydrophilic matrices as constant release devices (Geomatrix(Tm) Systems)
U Conte (1993)
10.1038/nbt.1504
Transdermal drug delivery
M. Prausnitz (2008)
10.1016/j.jconrel.2009.10.011
Development of a pH-responsive drug delivery system for enantioselective-controlled delivery of racemic drugs.
R. Suedee (2010)
10.1016/j.tips.2009.08.004
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Y. Malam (2009)
10.1016/S1050-1738(01)00161-X
The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine.
T. Sakai (2002)
10.1517/17425247.3.6.747
Delivery systems and adjuvants for oral vaccines
E. Lavelle (2006)
10.1007/s11095-005-9046-2
Polymer Architecture and Drug Delivery
L. Y. Qiu (2005)
10.1002/AIC.690491202
Advances in Biomaterials, Drug Delivery, and Bionanotechnology
R. Langer (2003)
10.1097/JNN.0b013e318193458b
Novel Drug Delivery Systems: Future Directions
Angelia Colwell Berkowitz (2009)
10.1002/JPS.10160
Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry.
H. K. Vaddi (2002)
The future of multihospital systems.
Kaiser Lr (1992)
Microfabricated microneedles: A novel approach to transdermal drug delivery
Henry. (1999)
10.1016/S1359-6446(01)01810-4
Muscle-based gene therapy and tissue engineering for the musculoskeletal system.
V. Wright (2001)
10.1124/MI.4.6.1
Transdermal drug delivery: PAST, PRESENT, FUTURE.
S. Scheindlin (2004)
10.1080/10717540490280750
Development and Characterization of Mucoadhesive Microspheres Bearing Salbutamol for Nasal Delivery
S. Jain (2004)
10.1089/109153601750124302
Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors.
S. Tirney (2001)
10.1016/S1048-6666(01)80023-9
Gene therapy and the future of cartilage repair
N. Adachi (2001)
10.1016/J.BIOMATERIALS.2005.11.008
In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
K. Y. Win (2006)
10.1089/TEN.2007.0096
Review: gene- and stem cell-based therapeutics for bone regeneration and repair.
N. Kimelman (2007)
10.1016/j.actbio.2008.11.006
Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications.
E. R. Balmayor (2009)
10.1016/j.addr.2003.10.025
Penetration enhancers.
A. Williams (2004)
10.1002/j.1552-4604.1990.tb03566.x
Drug Delivery Systems 4. Implants in Drug Delivery
V. Ranade (1990)
10.1201/B10846-7
Implants in Drug Delivery
V. Ranade (2011)
10.1002/JPS.10164
Effects of low-frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin.
H. Tang (2002)
10.1016/J.COPBIO.2003.10.007
Drug delivery in biotechnology: present and future.
G. Orive (2003)
10.1016/S8756-3282(03)00207-2
Localized insulin-like growth factor I delivery to enhance new bone formation.
L. Meinel (2003)
10.1152/PHYSREV.2003.83.3.835
Regulation of wound healing by growth factors and cytokines.
S. Werner (2003)
10.1016/S0378-5173(02)00024-8
Oral delivery of insulin from enteric-coated capsules containing sodium salicylate: effect on relative hypoglycemia of diabetic beagle dogs.
E. Hosny (2002)
10.1016/S1359-0286(02)00075-X
Drug delivery therapies I General trends and its importance on bone tissue engineering applications
P. B. Malafaya (2002)
10.1007/s10529-007-9312-y
Agarose–gelatin conjugate for adherent cell-enclosing capsules
S. Sakai (2007)
10.1016/J.ACTBIO.2006.06.007
Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation.
Y. Hong (2007)
10.1517/17425247.2.5.855
Oral pulsatile drug delivery systems
A. Maroni (2005)
10.1002/term.63
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts)
P. Bessa (2008)
10.1016/j.bone.2008.06.019
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model.
Zarana S. Patel (2008)
10.1016/j.ijpharm.2008.08.032
Micro-scale devices for transdermal drug delivery.
A. Arora (2008)
10.1089/TEN.2006.12.2665
Effects of auricular chondrocyte expansion on neocartilage formation in photocrosslinked hyaluronic acid networks.
C. Chung (2006)
10.5414/CPP42456
Safety and pharmacokinetics of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma.
B. Otulana (2004)
10.1146/ANNUREV.BIOENG.8.061505.095735
Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
V. Torchilin (2006)
10.1016/S1369-7021(09)70156-7
Nanofabrication by self-assembly
G. Ozin (2009)
10.1016/0378-5173(95)00122-Y
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
G. Liversidge (1995)
10.1038/nrd1304
Current status and future potential of transdermal drug delivery
M. Prausnitz (2004)
10.1016/S0169-409X(98)00054-4
Cyclodextrins in nasal drug delivery.
Merkus (1999)
10.1016/J.JCONREL.2006.06.017
PEG-modified gold nanorods with a stealth character for in vivo applications.
T. Niidome (2006)
10.1007/s11095-006-9173-4
Spatio–temporal VEGF and PDGF Delivery Patterns Blood Vessel Formation and Maturation
Ruth Chen (2006)
10.1073/pnas.2331316100
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies
D. Mcallister (2003)
10.1517/17425247.2.5.791
Microparticles for oral delivery of vaccines
G. Mutwiri (2005)
10.1517/17425247.2.4.625
Novel hydrofluoroalkane suspension formulations for respiratory drug delivery
P. Rogueda (2005)
10.1002/jps.21380
Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies.
J. Z. Yang (2008)
10.1023/A:1019829622088
Effect of Nanonization on Absorption of 301029: Ex Vivo and In Vivo Pharmacokinetic Correlations Determined by Liquid Chromatography/Mass Spectrometry
L. Jia (2004)
10.1016/J.ADDR.2007.03.012
Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications.
P. B. Malafaya (2007)
10.1002/CHIN.200138289
Hydrogels for Tissue Engineering
K. Lee (2001)
10.1038/sj.gt.3302515
Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)
H. Madry (2005)
10.1302/0301-620X.84B2.11167
Insulin-like growth factor-I enhances cell-based repair of articular cartilage.
L. Fortier (2002)
10.1038/nature02388
Designing materials for biology and medicine
R. Langer (2004)
10.1016/J.BIOMATERIALS.2006.05.021
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2.
L. Meinel (2006)
10.1073/pnas.0710355105
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
D. Wermeling (2008)
10.1016/J.BBRC.2005.11.180
Immune responses to an encapsulated allogeneic islet beta-cell line in diabetic NOD mice.
Sasha P Black (2006)
10.1016/J.VACCINE.2007.10.020
Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.
P. Laurent (2007)
10.1002/JBM.A.31213
Encapsulation and osteoinduction of human periodontal ligament fibroblasts in chitosan-hydroxyapatite microspheres.
Bülend Inanç (2007)
10.1586/17434440.4.1.55
Selfprotective smart orthopedic implants
J. Parvizi (2007)
10.2174/156720108783331041
Orthopedic implant used as drug delivery system: clinical situation and state of the research.
D. Pioletti (2008)
10.1016/S1461-5347(99)00238-2
Starch capsules: an alternative system for oral drug delivery.
Vilivalam (2000)
10.1038/sj.gt.3302396
Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy
A. Nixon (2005)
10.1016/J.CARRES.2007.07.007
Preparation and properties of a pH/temperature-responsive carboxymethyl chitosan/poly(N-isopropylacrylamide)semi-IPN hydrogel for oral delivery of drugs.
B. Guo (2007)
10.1023/A:1013395102049
Transdermal Delivery of Antisense Oligonucleotides with Microprojection Patch (macroflux®) Technology
W. Lin (2004)
10.1002/0471732877.EMD274
Drug Delivery Systems
D. Paolino (2006)
10.1111/j.1538-7836.2007.02386.x
Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis
E. A. Silva (2007)
10.1016/S0029-7844(99)00661-4
Dry Mouth With Conventional and Controlled‐Release Oxybutynin in Urinary Incontinence
E. Versi (2000)
10.1002/jgm.344
Gene therapy and tissue engineering for sports medicine
J. Huard (2003)
10.1002/BIT.21624
Production of cell‐enclosing hollow‐core agarose microcapsules via jetting in water‐immiscible liquid paraffin and formation of embryoid body‐like spherical tissues from mouse ES cells enclosed within these microcapsules
S. Sakai (2008)
10.1016/J.BIOMATERIALS.2007.09.008
Muscle-derived stem cells for tissue engineering and regenerative therapy.
A. Ūsas (2007)
10.3109/10611869509015943
Bioadhesives for optimization of drug delivery.
N. Peppas (1995)
10.1016/0142-9612(96)83284-4
Modulation of the dissolution profiles from Geomatrix multi-layer matrix tablets containing drugs of different solubility.
U. Conte (1996)
10.1016/S1359-0286(02)00077-3
Drug delivery therapies II. Strategies for delivering bone regenerating factors
P. B. Malafaya (2002)
10.3390/molecules14093754
Nasal Delivery of High Molecular Weight Drugs
Y. Ozsoy (2009)
10.1002/BIT.21452
A novel method of encapsulating and cultivating adherent mammalian cells within collagen microcarriers
T. Wu (2007)
Use of recrystallized lactose as carrier for inhalation powder of interferon a2b.
R. Jiang (2005)
10.1007/s11095-008-9707-z
Templated Open Flocs of Nanorods for Enhanced Pulmonary Delivery with Pressurized Metered Dose Inhalers
J. Engstrom (2008)
10.1016/J.BEJ.2006.02.003
Development of alginate–agarose subsieve-size capsules for subsequent modification with a polyelectrolyte complex membrane
S. Sakai (2006)
10.1016/0168-3659(93)90207-L
Multi-layered hydrophilic matrices as constant release devices (GeomatrixTM Systems)
U. Conte (1993)
Advances in the oral delivery of heparin from solid dosage forms using emisphere’s eligen® oral drug delivery technology
S. Majuru (2004)
10.1016/j.jconrel.2008.08.010
Cell microencapsulation technology: towards clinical application.
A. Murua (2008)
10.1016/j.injury.2008.01.034
Concepts in gene therapy for cartilage repair.
A. Steinert (2008)
Use of nanotechnologies for drug
P. Shah (2006)
10.1016/J.PROGPOLYMSCI.2008.07.005
Responsive polymers in controlled drug delivery
A. Bajpai (2008)
10.1177/0091270003261490
The Pharmacokinetics of Nebulized Nanocrystal Budesonide Suspension in Healthy Volunteers
W. Kraft (2004)
10.1016/J.EJPB.2007.04.021
Non-viral gene transfection technologies for genetic engineering of stem cells.
Jun-ichiro Jo (2008)
10.1016/0378-5173(95)00148-C
Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
G. Liversidge (1995)
10.1016/J.BIOMATERIALS.2007.01.021
Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells.
L. Ferreira (2007)
10.1038/nrd1088
The dawning era of polymer therapeutics
R. Duncan (2003)
10.1016/S1369-7021(09)70157-9
Nanofabrication by DNA self-assembly
H. Li (2009)
10.1177/088532829400800305
Implantable Drug Delivery
M. Nitsch (1994)
10.3109/03639040903517906
Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes
S. Gungor (2010)
10.4161/hv.1.3.1797
Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates
C. H. Dean (2005)
10.1038/nrd1494
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
10.1016/j.actbio.2010.07.018
A novel controlled drug delivery system based on pH-responsive hydrogels included in soft gelatin capsules.
G. Frutos (2010)
Market trends: disposable mono-dose autoinjectors and pen-injectors
I. Thompson (2008)
The next generation of auto-injectors
M. Young (2010)
10.1016/J.POLYMER.2008.01.027
HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES
T. Hoare (2008)



This paper is referenced by
Liposomes : a multifaceted delivery system
Sameer Joshi (2017)
10.1007/s40204-020-00143-2
Engineered PLGA-PVP/VA based formulations to produce electro-drawn fast biodegradable microneedles for labile biomolecule delivery
Valentina Onesto (2020)
10.1097/MOT.0000000000000564
Novel targeted drug delivery systems to minimize systemic immunosuppression in vascularized composite allotransplantation
A. Taddeo (2018)
10.1002/SMTD.201700347
Immunostimulation and Immunosuppression: Nanotechnology on the brink
F. Fontana (2018)
10.1039/c5cc01025j
DNA-ligand interactions gained and lost: light-induced ligand redistribution in a supramolecular cascade.
D. Berdnikova (2015)
10.1016/J.APSUSC.2017.12.066
Surfactant mediated interaction of vancomycin with silver nanoparticles
Amritpal Kaur (2017)
10.3390/nano6050087
Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization
Alice Polchi (2016)
10.1007/978-981-15-0283-5_5
pH Sensed Interpenetrating Polymeric Network: Application in Drug Delivery
B. Mishra (2020)
10.1038/srep13820
Thermal post-treatment alters nutrient release from a controlled-release fertilizer coated with a waterborne polymer
Zijun Zhou (2015)
10.1021/acsami.7b18245
Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells.
C. Maiti (2018)
10.1016/j.addr.2014.02.002
Delivery of antibiotics with polymeric particles.
Meng-Hua Xiong (2014)
10.4155/tde-2019-0057
Formulation of sustained release microspheres of cefixime with enhanced oral bioavailability and antibacterial potential.
Karan Razdan (2019)
Polysaccharide based nanoparticles for drug delivery applications
Helene Jonassen (2014)
10.2217/pgs.12.157
Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.
D. Della-Morte (2012)
10.1002/med.21463
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights
Ping-Pin Zheng (2018)
10.1016/j.cimid.2016.12.001
Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Kai-Jen Hsueh (2017)
Smart Biomaterials and Systems for Bone Tissue Engineering
Esmat Alemzadeh (2020)
10.1253/CIRCJ.CJ-12-0132
Cardioprotection From Ischemia/Reperfusion Injury
T. Minamino (2012)
10.3390/ijms13033847
Functionalized Nanostructures with Application in Regenerative Medicine
M. Perán (2012)
10.1021/la302608g
Correlation of the physicochemical and structural properties of pDNA/cationic liposome complexes with their in vitro transfection.
T. A. Balbino (2012)
10.1007/S12649-012-9146-2
Towards a Greener Pharmacy by More Eco Design
M. Baron (2012)
10.1016/J.CNSNS.2016.09.017
A memory-based model for blood viscosity
C. Ionescu (2017)
10.2217/nnm.12.78
From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering.
V. E. Santo (2012)
10.1021/ac303405x
On-chip assessment of the protein-release profile from 3D hydrogel arrays.
M. Oliveira (2013)
10.1007/s11051-012-1305-7
Design of Au/SPIO composite nanoparticle for facile and biocompatible surface functionalization via Au–S bond
Satoshi Seino (2012)
10.1016/B978-0-323-46143-6.00023-3
Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook
P. Furneri (2017)
10.1039/C3BM00175J
One-step fabrication of core-shell structured alginate-PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs.
M. Lim (2013)
10.1021/cr300047q
Can controversial nanotechnology promise drug delivery?
Venkat Ratnam Devadasu (2013)
10.1007/BF03261887
A Perspective on Bioactive Cell Microencapsulation
Argia Acarregui (2012)
Thermoresponsive polymers in controlled drug delivery and gene delivery
Maria Teresa Rebelo Calejo (2013)
10.1021/nn2033105
Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
Y. Gao (2011)
10.1016/B978-0-12-415759-0.00025-X
Chapter 25 – Biopharmaceuticals
W. Halpern (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar